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Objective: To characterize the tissue and cellular changes found in trachomatous scarring (TS) and inflam-
mation using in vivo confocal microscopy (IVCM).
Design: Two complimentary case-control studies.
Participants: The first study included 363 cases with TS (without trichiasis), of whom 328 had IVCM
assessment, and 363 control subjects, of whom 319 had IVCM assessment. The second study included 34 cases
with trachomatous trichiasis (TT), of whom 28 had IVCM assessment, and 33 control subjects, of whom 26 had
IVCM assessment.
Methods: All participants were examined with 2.5 loupes. The IVCM examination of the upper tarsal
conjunctiva was carried out with a Heidelberg Retina Tomograph 3 with the Rostock Cornea Module (Heidelberg
Engineering GmbH, Dossenheim, Germany).
Main OutcomeMeasures: The IVCM images were graded in a masked manner using a previously published
grading system evaluating the inflammatory infiltrate density; the presence or absence of dendritiform cells (DCs),
tissue edema, and papillae; and the level of subepithelial connective tissue organization.
Results: Subjects with clinical scarring had a characteristic appearance on IVCM of well-defined bands and
sheets of scar tissue visible. Similar changes were also seen in some clinically normal subjects consistent with
subclinical scarring. Scarred subjects had more DCs and an elevated inflammatory infiltrate, even after adjusting
for other factors, including the level of clinical inflammation. Cellular activity was usually seen only in or just below
the epithelium, rarely being seen deeper than 30 m from the surface. The presence of tissue edema was
strongly associated with the level of clinical inflammation.
Conclusions: In vivo confocal microscopy can be quantitatively used to study inflammatory and scarring
changes in the conjunctiva. Dendritic cells seem to be closely associated with the scarring process in trachoma
and are likely to be an important target in antifibrotic therapies or the development of a chlamydial vaccine. The
increased number of inflammatory cells seen in scarred subjects is consistent with the immunopathologic nature
of the disease. The localization of cellular activity close to the conjunctival surface supports the view that the
epithelium plays a central role in the pathogenesis of trachoma.
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed
in this article. Ophthalmology 2011;118:2138–2146
© 2011 by the American Academy of Ophthalmology.Open access under CC BY license.e
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tTrachoma is a chronic, cicatrizing keratoconjunctivitis and
is the most common infectious cause of blindness globally.1
Trachoma is caused by infection with Chlamydia tracho-
matis, serovars A–C. In endemic regions, chlamydial infec-
tion is most frequently found in children, who develop a
follicular and papillary conjunctivitis and sometimes cor-
neal pannus (vascular infiltration). After repeated episodes
of infection and inflammation, the scarring complications of
trachoma develop: conjunctival scarring, entropion, trichia-
sis, and corneal opacity. Although there has been an en-
couraging downward trend in the number of people with
active trachoma over the last 3 decades, this disease remains
a significant public health problem in 50 countries.2
Despite numerous studies on the pathogenesis of scarring
trachoma, the factors driving the late-stage scarring process
and the immunofibrogenic responses involved remain to be t
2138 © 2011 by the American Academy of Ophthalmology 
Published by Elsevier Inc. Open access under CC BY license. lucidated.3 In vivo confocal microscopy (IVCM) is a new
echnique that provides high-resolution images of the ocular
urface down to the cellular level. It has been used to study
 wide range of infectious, inflammatory, and metabolic
isease processes affecting the ocular surface.4–9 We have
reviously reported a description of the main features of
rachoma seen with IVCM and a new grading system for the
uantitative assessment of these images.10 With the use of
VCM, one can assess the type and density of inflammatory
ell infiltrates and the morphology and distribution of fi-
rotic tissue within the tarsal conjunctiva. In vivo confocal
icroscopy is noninvasive, has no adverse effects, and can
e repeated in the same individual.
To better understand the disease process in scarring
rachoma, we conducted 2 case-controls studies looking at
he IVCM findings in individuals with mild-moderate scar-
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Hu et al  IVCM in Scarring Trachomaring (trachomatous scarring [TS]) and severe scarring (tra-
chomatous trichiasis [TT]) compared with normal controls.
It is anticipated that this technology can be used to support
the detailed assessment of progressive scarring in the study
of both current and future interventions in trachoma control.
Patients and Methods
Ethical Permission and Subject Recruitment
This study was approved by ethics committees in Tanzania and the
United Kingdom; written, informed consent was obtained from
each subject. The first study, on trachomatous scarring, was con-
ducted in the Siha District of the Kilimanjaro Region of Northern
Tanzania, in what was historically a single village. Two years
before the study, this village was subdivided into 3 administrative
units that form a single continuous geographic entity. Previous
surveys of children in this village found a moderate level of active
trachoma (18% follicular trachoma in children aged 1–9 years).
After an initial census, adults with conjunctival scarring (grade
S1b or worse, see below) were recruited as cases. An equal number
of control subjects without scarring, frequency matched by ethnic-
ity, were recruited. Individuals with trichiasis or previous eyelid
surgery were excluded from this study.
Most of the cases in the TS study had relatively mild
conjunctival scarring. Therefore, to characterize the full range
of the scarring phenotype, a second case-control study was
conducted in which all the cases were individuals with tracho-
matous trichiasis (TT), who generally had more severe conjunc-
tival scarring. The cases in the TT study were recruited from
patients undergoing trichiasis surgery in the Kilimanjaro Re-
gion. Control subjects were recruited from patients undergoing
cataract or retinal detachment surgery at Kilimanjaro Christian
Medical Centre.
Clinical Assessment
All subjects were examined by an ophthalmologist (VH) using
2.5 loupes and a bright torch. Examinations were carried out in
a darkened tent or room. The 1981 World Health Organization
trachoma grading system was used to grade conjunctival follicles
and papillae, entropion, trichiasis, and corneal opacity.11 We de-
veloped a more detailed grading system for conjunctival scarring
(Table 1 and Fig 1, available at http://aaojournal.org). A slit lamp
was used to rule out subtle conjunctival scarring in normal
controls.
Confocal Microscopy Assessment
The IVCM examination of the upper tarsal conjunctiva was
performed using the Heidelberg Retina Tomograph 3 in com-
bination with the Rostock Corneal Module (Heidelberg Engi-
neering GmbH, Dossenheim, Germany) using a previously de-
scribed protocol.10 For the TS study, all IVCM assessments
were done on the left eye, whereas for the TT study a mixture
of right and left eyes were examined. Ten “volume” scans were
taken from random locations across the tarsal conjunctiva, each
of which consisted of 40 coronal scans taken in rapid succession
at 2.1-m intervals, starting at the conjunctival surface, moving
from superficial to deep.
The IVCM images were graded for inflammatory features (Fig
2) and the degree of subepithelial connective tissue organization
(Fig 3).10 All IVCM grading was performed by a single observer
(VH) who was masked to the clinical status of the patient, with the (xception of the cell counts for the inflammatory infiltrate in the
S study, which was done by a single trained observer. For every
ubject, each volume scan was assessed and scored: 0 (normal), 1
grade 1), 2 (grade 2), or 3 (grade 3) for the connective tissue
rganization grading. The overall connective tissue organization
core for that subject was calculated by dividing the sum of these
eparate volume scan scores by the number of volume scans
raded. Individuals with fewer than 3 gradable volume scans were
xcluded from the analysis. We have previously reported good
nterobserver agreement (intraclass coefficient of 0.88).10
ample Size and Data Analysis
hese studies are part of a series of related studies on the patho-
enesis of TS with the sample size calculated to encompass these
ther components. For example, the sample of 363 cases and 363
ontrols has 85% power to detect an association of a factor with
n odds ratio (OR) of 2 when the factor is present in 10% of
ontrol subjects.
Data were entered into Access 2007 (Microsoft Corp, Red-
ond, WA) and analyzed using STATA 11.0 (StataCorp LP,
ollege Station, TX). Logistic regression models were developed
or clinical scarring to estimate ORs and 95% confidence intervals
CIs) for association with demographic and categoric IVCM char-
cteristics. In view of the differences in ages between cases and
ontrols in the TS study and the known association of TS with age,
ll ORs were age-adjusted. Linear regression (age-adjusted for the
S study) was used to estimate the strength of associations be-
ween clinical scarring and continuous IVCM variables (inflam-
atory infiltrate and connective tissue organization score). The TS
tudy had a larger number of participants, so a more detailed
nalysis is also presented for this study. Multivariable logistic
egression models (for categoric outcomes) and multivariable lin-
ar regression models (for continuous outcomes) were fitted to
ssess whether IVCM characteristics were independently associ-
ted with the presence of scarring, the level of scarring, and the
evel of clinical inflammation after adjusting for potential con-
ounding factors. Likelihood ratio tests were used to assess the
trength of association of factors with scarring. Tests for nonlin-
arity were conducted to assess whether fitting factors on a linear
cale provided an adequate fit to the data. Tests for trend were used
o examine the association of IVCM parameters with the ordered
ategories of clinical scarring and inflammation severity using the
ald test.
esults
tudy Participants
he TS study village had an adult population of 3626, of whom
418 (67%) were seen. Of the 1208 individuals not seen, the
ajority (58.9%) were absent during the census, despite 2
isits; 9.6% were temporarily resident elsewhere; and 4.1%
efused examination. Of the 2418 participants seen, we ex-
luded 36 (1.5%) because of the presence of trichiasis, previous
yelid surgery, or inability to give informed consent. Of the
emaining 2382 participants, 862 (36.2%) had clinically appar-
nt TS and 1520 (63.8%) did not have visible scarring. We
ecruited 363 TS cases and 363 controls. Demographic and
linical characteristics are shown in Table 2. Cases were sig-
ificantly older than controls (P  0.001), so subsequent anal-
ses were adjusted for age. The majority of cases and controls
ere of Maasai ethnicity (77% of both groups) followed by
hagga ethnicity (11% of both groups).
We recruited 34 cases and 33 controls for the TT study
Table 3). There was no significant difference between the ages of
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Ophthalmology Volume 118, Number 11, November 2011TT cases and controls. The majority of the cases (85%) were
Maasai, whereas the controls were more evenly divided between
different ethnic groups (the largest groups were Chagga, 42%, and
Pare, 24%).
Analysis Based on Case-Control Status
The clinical scarring was mostly mild to moderate in the TS study
and severe in the TT study (Tables 2 and 3). Most of the cases were
clinically inflamed; in contrast, most controls were not. In the TT
study most cases had severe clinical scarring (70% with S3), in
contrast with the TS study (3.6% with S3).
In all participants, most of the cellularity detected by IVCM
was found within the most superficial 20 –30 m of the con-
junctiva, with cells not usually seen below this level. There
were more inflammatory cells in cases than controls, signifi-
Figure 2. In vivo confocal microscopy grading system of inflammatory fe
bright white nuclei. The mean inflammatory cell density of 3 randoml
density of cells from within the volume scan is used. B, Dendritiform
per volume scan needs to be 1. The largest number of DCs in any in
of 1 is used to differentiate occasional DCs seen in scans of otherwi
Graded as present or absent (present if seen in any volume scan). D, Pa
or absent (present if seen in any volume scan).cantly so in the larger TS study (Table 4). Cases were also more s
2140ikely than controls to have dendritiform cells (DCs) and tissue
dema present, but there was no association with the presence
f papillae (Table 4).
The mean IVCM connective tissue organization score was
igher in cases than in controls in both studies, but particularly
n the TT study in which the cases had more severe clinical
carring (TT cases 2.29 vs. controls 0.59; P  0.001; Table 4).
he tissue organization score was similar in the control groups
f both studies (TT study controls 0.59 vs. TS study controls
.77). The IVCM connective tissue organization score was
ategorized into 3 groups (0 –1, 1–2, and 2–3). In both
tudies, the majority of controls had a score of 1 (79% in the
S study and 92% in the TT study), compared with the cases
26% in the TS study and 8% in the TT study). Most of the
ases in the TS study (63/81; 78%) with an IVCM score in the
owest 0 –1 category had the mildest degree of clinical
s. Images are 400400 m. A, Inflammatory infiltrate: seen as multiple
cted volume scans is calculated. The individual scan with the highest
graded as present or absent. To be present, the mean number of DCs
ual scan in a volume scan is used for measurement. A mean number
rmal subjects. C, Tissue edema: seen as multiple black empty spaces.
: seen as elevations with a central vascular network. Graded as presentature
y sele
cells:
divid
se no
pillaecarring, S1b. There were no controls in either study with the
c
(
h
i
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Hu et al  IVCM in Scarring Trachomahighest IVCM connective tissue organization category (2–3),
which is characterized by clearly defined bands or sheets of
tissue.
A multivariable logistic regression model of the TS study
Figure 3. In vivo confocal microscopy grading system for conjunctival c
scarring are seen within a particular volume scan, then the highest grade i
associated with the vascular tissue; if this is not possible, then the scan isshowed that after controlling for age and clinical inflammation, 3linical scarring remained associated with the presence of DCs
OR 4.27, 95% CI, 1.39 –13.09, P0.008, Table 5, available at
ttp://aaojournal.org). The corresponding adjusted association
s even stronger for the TT study (OR 25.36, 95% CI, 1.69 –
tive tissue organization. Images are 400400 m. If different grades of
rded. The connective tissue that is graded needs to be separate from that
idered ungradable.onnec
s reco80.00, P  0.02). Tissue edema was not significantly associ-
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Ophthalmology Volume 118, Number 11, November 2011ated with scarring after adjusting for age and clinical
inflammation.
Analysis Based on Clinical Scarring Grade (TS
Study Only)
The IVCM inflammatory infiltrate, connective tissue organiza-
tion score, presence of DCs, and presence of tissue edema all
increased with the clinical scarring grade (Table 6, available at
http://aaojournal.org). Regression models were used to analyze
the association of each of these factors adjusting for age, sex,
and the clinical inflammation grade. For modeling purposes,
Table 2. Demographic and Clinical Characteristics of the Trach
with Conju
Parameter
Cases
N  363
n (%)
Demographic Characteristics
Sex
Female 222 (61.2)
Male 141 (38.8)
Age (year groups)
18–25 29 (8.0)
25–35 53 (14.6)
35–45 65 (17.9)
45–55 81 (22.3)
55–65 58 (16.0)
 65 77 (21.2)
Age (yrs) [median, IQR] 49.7 36.7–62.7
Formal education†
None 250 (69.4)
1–7 yrs 106 (29.4)
 7 yrs 4 (1.1)
BMI‡
Underweight 55 (15.3)
Normal 259 (72.0)
Overweight/obese 46 (12.8)
Clinical Characteristics
Scarring grade§
S0 – –
S1a 0 0
S1b 188 (51.8)
S1c 128 (35.3)
S2 34 (9.4)
S3 13 (3.6)
Papillary inflammation grade
P0 81 (22.3)
P1 189 (52.1)
P2 85 (23.4)
P3 8 (2.2)
Follicles grade
F0 358 (98.6)
F1 2 (0.6)
F2 1 (0.3)
F3 2 (0.6)
BMI  body mass index; CI  confidence interval; IQR  interquartile
*The result shown is the increase in the OR with each increase in age g
†Primary schooling in Tanzania is completed after 7 years.
‡Categories from the National Institutes of Health.
§All of the controls had no scarring (grade 0), and all of the cases had scclinical scarring grades S2 and S3 were combined, because 2
2142here were few individuals in clinical scarring grade S3 in the
S study. For each unit increase in the clinical scarring grade,
here was an independent increase of 87 cells/mm2 in the
nflammatory infiltrate (95% CI, 45–130; P  0.001) and of
.36 in the organization score (95% CI, 0.29 – 0.43; P  0.001).
imilarly, the OR for the presence of DCs increased by 1.68
95% CI, 1.14 –2.47, P  0.008) for each increase in clinical
carring grade. The presence of tissue edema was not signifi-
antly associated with increasing clinical scarring grade (OR 
.83, 95% CI, 0.43–1.61).
For reference, the mean connective tissue organization score
or clinical scarring grade S3 in the TT study was 2.65 (95% CI,
ous Scarring Study Participants and Age-Adjusted Associations
al Scarring
Controls
N  363 Age-Adjusted Association with Scarring
(%) OR 95% CI P Value
(66.7) 1.00 –
(33.3) 1.19 0.83–1.71 0.34
2.20* 1.94–2.50 0.001
(32.2)
(31.4)
(24.0)
(7.7)
(2.5)
(2.2)
22.2–39.2
0.001
(46.1) 1.00 – –
(49.2) 0.57 0.40–0.81
(4.7) 0.25 0.07–0.88
0.48
(8.4) 1.39 0.79–2.44
(80.2) 1.00 – –
(11.5) 1.14 0.68–1.92
(100)
–
–

–

(95.3)
(4.7)
(0.0)
(0.0)
(99.7)
(0.3)
(0.0)
(0.0)
; OR  odds ratio.
ategory.
g grade S1b.omat
nctiv
n
242
121
117
114
87
28
9
8
29.2
166
177
17
30
287
41
363
–
–

–

346
17
0
0
358
1
0
0
range
roup c
arrin.36–2.94). Of these severely scarred cases, 13 of 16 (81%) were
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Hu et al  IVCM in Scarring Trachomain the highest IVCM organization grade 2–3, and 3 of 16 (19%)
were in the intermediate grade 1–2.
Analysis Based on Clinical Inflammation Grade
(TS Study Only)
The IVCM inflammatory infiltrate, connective tissue organization
score, presence of DCs, and presence of tissue edema all tended to
increase with the clinical inflammation grade (Table 7, available at
http://aaojournal.org). Regression models were used to analyze the
association of each of these factors, adjusting for age, sex, and
clinical scarring grade, in a similar manner to that above. For each
unit increase in the clinical inflammation grade, there was a small
increase in the inflammatory infiltrate, but this was of only bor-
derline statistical significance (P  0.06). After adjusting for the
other factors, the organization score no longer remained signifi-
cantly associated with the level of clinical inflammation. The
presence of DCs did remain associated with the level of clinical
Table 3. Demographic and Clinical Characteristics of the T
Conjunct
Cases N  34
Parameter n (%)
Demographic Characteristics
Sex
Female 23 (67.7)
Male 11 (32.3)
Age (year groups)
18–25 0 (0.0)
25–35 0 (0.0)
35–45 1 (6.9)
45–55 1 (20.7)
55–65 10 (20.7)
 65 22 (51.7)
Age (yrs) [median, IQR] 68.5 61.0–80.0
Formal education†
None 28 (87.5)
1–7 yrs 4 (12.5)
7 yrs 0 (0.0)
BMI Data not collected
Clinical Characteristics
Scarring grade‡
S0 – –
S1a 0 0
S1b 0 0
S1c 6 (17.7)
S2 4 (11.8)
S3 24 (70.6)
Papillary inflammation grade
P0 4 (11.8)
P1 5 (14.7)
P2 17 (50.0)
P3 8 (23.5)
Follicles grade
F0 34 (100.0)
F1 0 (0.0)
F2 0 (0.0)
F3 0 (0.0)
BMI  body mass index; CI  confidence interval; IQR  interquartile
*The result shown is the increase in the OR with each increase in age g
†Primary schooling in Tanzania is completed after 7 years.
‡All of the controls had no scarring (grade 0), and all of the cases had scinflammation (P0.03), especially for the highest grade of inflam- cation (OR 12.1, 95% CI, 2.1–69.2). With each increase in
linical inflammation grade, there was an increase of 5.12 in the
R for the presence of tissue edema (95% CI, 2.69–9.76,
0.001).
iscussion
n this study, IVCM was used to examine tissue changes in
large number of people with trachomatous conjunctival
carring and compared with controls. Previously developed
rading systems were used to formally evaluate tissue mor-
hology and cellular appearances.
Previous studies have shown that the cellular infiltrate is
robably composed of inflammatory cells, such as neutro-
hils or lymphocytes, and is increased in patients with
topic keratoconjunctivitis.8,12-15 In vivo confocal micros-
matous Trichiasis Study Participants and Associations with
Scarring
ntrols N  33 Association with Scarring
(%) OR 95% CI P Value
(45.5) 1.00 –
(54.5) 2.61 0.93–7.34 0.06
1.62* 0.90–2.95 0.11
(0.0)
(0.0)
(6.1)
(21.2)
(18.2)
(54.6)
53.1–78.1
0.001
(13.3) 1.00 – –
(60.0) 0.02 0.00–0.12
(26.7) 0.02 0.00–0.18
(100)
–
–
–
–
–
(93.9)
(3.0)
(3.0)
(0.0)
(100.0)
(0.0)
(0.0)
(0.0)
; OR  odds ratio.
ategory.
g grade S1c.racho
ival
Co
n
15
18
0
0
2
7
6
18
70.0
4
18
8
33
–
–
–
–
–
31
1
1
0
33
0
0
0
range
roup copy assessment of the inflammatory cell density also has
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Ophthalmology Volume 118, Number 11, November 2011shown good correlation with assessment by brush cytol-
ogy.15 Some attempt can be made to differentiate these cells
on the basis of nuclear detail, for example, segmentation
suggesting polymorphs, but definitive identification would
require biopsy. We found that the inflammatory cell density
increased with increasing clinical scores for both conjunc-
tival inflammation and scarring. The association with scar-
ring was greater than with inflammation and remained
strongly significant even after adjusting for the level of
clinical inflammation. This suggests that the increased cel-
lularity may be more closely related to the scarring process
than clinically visible “inflammation,” which is character-
ized by erythema and edema.
Dendritiform cells were found to be independently asso-
ciated with trachomatous scarring. These cells have invari-
ably been labeled as dendritic cells in previous studies of the
ocular surface using IVCM, although there has not been
definitive histologic confirmation of this finding.7,16 Den-
dritic cells play a central role in determining the type of
immune response that develops to response to infection,
which is of particular relevance in trachoma because the
tissue damage is immune mediated.17-21 The view that den-
Table 4. In vivo confocal microscopy findings from the Trachom
with conju
Parameter Cases
N  328*
TS Study
Mean inflammatory infiltrate (cells/mm2)
[mean, 95%CI]
875 832–919
Dendritiform cells present, n(%) 50 (15.2)
Tissue edema present, n(%) 22 (6.7)
Papillae present, n(%) 110 (33.5)
N  314
Connective Tissue Organization grade, n(%)
0–1 81 (25.8)
1–2 178 (56.7)
2–3 55 (17.5)
Mean connective tissue organization score (mean, 95%CI)
1.48 1.41–1.56
TT Study
N  28
Mean inflammatory infiltrate (cells/mm2)
[mean, 95%CI]
1572 1174–1972
Dendritiform cells present, n(%) 16 (61.5)
Tissue edema present, n(%) 10 (38.5)
Papillae present, n(%) 0 (0.0)
N  26
Connective Tissue Organization grade, n(%)
0–1 2 (8.0)
1–2 6 (24.0)
2–3 17 (68.0)
Mean connective tissue organization score (mean, 95%CI)
2.29 1.94–2.64
OR  Odds ratio; CI  Confidence intervals; TS  Trachomatous Scar
*There are different N numbers as not all subjects had images which cou
†Age-adjusted for the TS Study.
‡Age-adjusted difference between cases and controls.
§If a cell contained 0 then a participant was moved up a category in ordedritic cells are likely to play an important role in the design c
2144f any chlamydial vaccine gains some support from our
tudy.22
Of note, most of the cells seen in these adults with TS
ere within the superficial 30 m of the surface. This
istribution suggests close interaction between these cells
nd the epithelium and lends support to the cellular para-
igm of chlamydia pathogenesis. The cellular paradigm
uggests that non-immune host cells, particularly epithelial
ells, release proinflammatory cytokines and chemokines in
esponse to chlamydial and other bacterial infection, which
nduces an inflammatory response leading to tissue dam-
ge.3,23,24 This is in contrast with the immunologic para-
igm, which argues that the damage is primarily driven by
n acquired cell-mediated immune response that is impor-
ant for defense against infection but also leads to collateral
issue damage.22
Some attempt has been made at grading the density of
onjunctival subepithelial connective tissue in relation to
lebs after trabeculectomy surgery.25 However, no clear
efinitions were provided for this grading system, nor was
here any evaluation of interobserver variation. In this arti-
s Scaring and Trachomatous Trichiasis Studies and associations
al scarring
Controls Association with scarring†
OR 95%CI P Value
N  319*
674 640–707 154‡ 90–217 0.001
7 (2.2) 4.10 1.71–9.85 0.002
9 (2.8) 3.77 1.53–9.26 0.004
129 (40.4) 1.14 0.78–1.66 0.49
N  302
0.001
238 (78.8) 1.00 –
64 (21.2) 6.2 4.1–9.4
0 (0.0) 107.4§ 14.2–813.7
0.77 0.71–0.82 0.59‡ 0.48–0.69 0.001
N  26
252 1037–1467 0.11
1 (3.6) 43.20 5.05–369.6 0.001
0 (0.0) 16.9§ 1.97–144.4 0.01
3 (10.7) 0.33§ 0.03–3.43 0.36
N  25
0.001
24 (92.3) 1.00 –
2 (7.7) 72.0 5.6–933.0
0 (0.0) 204.0§ 17.1–2434.9
0.59 0.41–0.77 0.001
TT  Trachomatous Trichiasis.
graded.
e able to generate a representative odds ratio.atou
nctiv
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ld bele, we have applied the use of a grading system that has
m
g
b
h
o
s
t
R
1
1
1
1
1
1
1
Hu et al  IVCM in Scarring Trachomaclear definitions and good interobserver agreement with the
graders masked to the clinical findings.10 This study showed
that scarring of the conjunctiva has a characteristic appear-
ance on IVCM with well-defined bands or sheets of scarring
seen. These probably represent collagen fibers. The IVCM
organization score tended to show an increase with the
clinical scarring grade. Most of the cases in the TT study
had severe scarring, and most were also scored as being in
the highest IVCM connective tissue organization grade,
showing good agreement between clinical and IVCM as-
sessment. Not all cases had an IVCM appearance suggestive
of scarring, with some having a homogenous appearance
similar to control subjects. However, most of these had very
mild clinical scarring.
Some control subjects also had a more organized
appearance of the connective tissue. This may represent
limitations in the grading system or the quality of the
images gained by the microscope. However, we have also
performed tarsal conjunctival IVCM with a similar pro-
tocol on 30 healthy volunteer subjects from a variety of
non-trachoma endemic areas (mean age 36.7 years, range
22– 85 years). These scans were graded in a masked
manner (mixed with scans from cases with scarring so
that the grader, VH, did not know the clinical status), and
the mean IVCM connective tissue organization score was
0.40 (95% CI, 0.27– 0.54) with all individuals graded as
being in the lowest IVCM organization grade. Although
this may reflect differences based on ethnicity, an alter-
native explanation is that the confocal microscope is able
to detect subclinical scarring. Many of the control sub-
jects in both case-control studies presented were proba-
bly exposed to chlamydial infection as children. There is
likely to be a spectrum of scarring severity seen in the
population, some of which may not be visible clinically
but can be detected with the confocal microscope. This
may be represented by the 20% of clinically normal
subjects in the TS study with an intermediate grade of
IVCM organization. This is supported by the observation
that in people from non-trachoma endemic areas, the
mean IVCM organization score was lower than that of the
controls in both case-control studies, and that the entire
group had only the lowest grade of IVCM organization.
There are a number of limitations to these studies. In the
TS study, cases tended to be older than controls. However,
we adjusted for this in the analysis. The age distribution was
similar between cases and controls in the TT study. Also,
not all potential study participants were able to tolerate
confocal microscopy. However, we think it is unlikely that
any systematic bias was introduced that would have affected
the results. We are currently comparing IVCM findings with
paired histology specimens to further validate the interpre-
tation of these observations. These studies were conducted
in a district previously found to be endemic for trachoma,
and results may differ in other areas/countries, for example,
where levels of infection are hyperendemic. Although the
cases and controls in the TS study were recruited from the
same community, the controls in the TT study were from a
mixture of urban and rural areas.
In conclusion, these studies have used IVCM to ex-
plore the cellular and tissue changes occurring in tracho-atous conjunctival scarring and inflammation. A robust
rading system has been used, and new insights have
een gained into the pathologic mechanisms at work. We
ope the grading system may be of relevance in the study
f other immunofibrogenic diseases of the conjunctiva,
uch as mucous membrane pemphigoid and atopic kera-
oconjunctivitis.
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